TP53 and chlamydia trachomatis infectious disease: For example, use of a PI3K inhibitor (LY294002) was investigated in an in vitro study of chlamydial infection (Siegl et al., 2014), in this study, PI3k inhibition dramatically stabilized P53 levels in infected human umbilical vein endothelial cells.